Birthweight, Childhood BMI: What Drives the Link? - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Birthweight, Childhood BMI: What Drives the Link?

Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.

  • By

  • Andrea Surnit

  • May 26, 2026

  • 3 min

Share

Objective:

To evaluate the associations between pregnancy-related conditions, birth phenotypes, and growth outcomes in mid-childhood, focusing on the roles of genetic factors.

Key Findings:
  • A 1-unit increase in birthweight was associated with a 0.45-unit increase in mid-childhood height, equating to approximately 2.3 cm at age 8.
  • The relationship between birthweight and mid-childhood BMI was predominantly driven by genetic pleiotropy, not direct intrauterine effects.
  • No strong evidence was found linking gestational hypertension or preeclampsia to mid-childhood BMI or height.
Interpretation:

The study suggests that intrauterine exposures related to gestational diabetes, hypertension, preeclampsia, birthweight, gestational duration, and placental weight are unlikely to be key drivers of mid-childhood BMI or height.

Limitations:
  • Genetic instruments explained only a modest proportion of exposure variability, potentially reducing power to detect small effects.
  • Outcomes were limited to mid-childhood anthropometric measurements, which may not apply to earlier childhood or adolescence.
  • The study population was exclusively of European ancestry, limiting generalizability.
Conclusion:

The findings indicate that genetic factors play a significant role in the association between birthweight and mid-childhood height, while the relationship with BMI is influenced by genetic pleiotropy.

Original Source(s)

Birthweight, Childhood BMI: What Drives the Link?

  • by Andrea Surnit

  • May 26, 2026

Related Content

CGM Shows Potential for Diagnosing Diabetes in Pregnancy

Early glucose patterns may help identify risk, but evidence doesn't support replacing standard testing.

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.